{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:41:22Z","timestamp":1792665682755,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jid.2017.07.845","type":"journal-article","created":{"date-parts":[[2017,8,26]],"date-time":"2017-08-26T20:01:53Z","timestamp":1503777713000},"page":"2578-2587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion"],"prefix":"10.1016","volume":"137","author":[{"given":"Prudence","family":"Donovan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier A.","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Kallioinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine W.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Muehlethaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donata","family":"Rimoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6256-3891","authenticated-orcid":false,"given":"Daniel B.","family":"Constam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.07.845_bib1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1523-1747.2000.00045.x","article-title":"Transforming growth factor beta1 induces apoptosis in normal melanocytes but not in nevus cells grown in type I collagen gel","volume":"115","author":"Alanko","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.07.845_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ncomms1585","article-title":"Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response","volume":"2","author":"Antsiferova","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2017.07.845_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.15252\/emmm.201606493","article-title":"Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages","volume":"9","author":"Antsiferova","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jid.2017.07.845_bib4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/bjc.2016.255","article-title":"Transforming growth factor beta as regulator of cancer stemness and metastasis","volume":"115","author":"Bellomo","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2017.07.845_bib5","first-page":"4596","article-title":"The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A","volume":"60","author":"Breit","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2017.07.845_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","article-title":"A\u00a0Switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma","volume":"24","author":"Caramel","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2017.07.845_bib7","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2017.07.845_bib8","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3748\/wjg.14.1699","article-title":"Activins and activin antagonists in hepatocellular carcinoma","volume":"14","author":"Deli","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jid.2017.07.845_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jid.2017.07.845_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/newbio242148a0","article-title":"Selection of successive tumour lines for metastasis","volume":"242","author":"Fidler","year":"1973","journal-title":"Nat New Biol"},{"key":"10.1016\/j.jid.2017.07.845_bib11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1084\/jem.20050463","article-title":"Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2017.07.845_bib12","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm1001-1118","article-title":"Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells","volume":"7","author":"Gorelik","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2017.07.845_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0092-8674(00)80720-5","article-title":"The EGF-CFC protein one-eyed pinhead is essential for nodal signaling","volume":"97","author":"Gritsman","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jid.2017.07.845_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/B978-0-12-385961-7.00013-5","article-title":"The regulation and functions of Activin and Follistatin in inflammation and immunity","volume":"85","author":"Hedger","year":"2011","journal-title":"Vitam Horm"},{"key":"10.1016\/j.jid.2017.07.845_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/jid.2014.328","article-title":"Activin A is anti-lymphangiogenic in a melanoma mouse model","volume":"135","author":"Heinz","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.07.845_bib16","doi-asserted-by":"crossref","first-page":"13388","DOI":"10.18632\/oncotarget.7796","article-title":"High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma","volume":"7","author":"Hoda","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2017.07.845_bib17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In\u00a0vivo switching of human melanoma cells between proliferative and invasive states","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2017.07.845_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0749.2006.00322.x","article-title":"Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature","volume":"19","author":"Hoek","year":"2006","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jid.2017.07.845_bib19","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1038\/sj.onc.1208900","article-title":"Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in\u00a0vitro and in\u00a0vivo","volume":"24","author":"Javelaud","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2017.07.845_bib20","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/0008-5472.CAN-06-3950","article-title":"Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis","volume":"67","author":"Javelaud","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2017.07.845_bib21","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/bjc.2011.348","article-title":"Activin A inhibits vascular endothelial cell growth and suppresses\u00a0tumour angiogenesis in gastric cancer","volume":"105","author":"Kaneda","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2017.07.845_bib22","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1158\/0008-5472.CAN-05-3821","article-title":"Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors","volume":"66","author":"Krneta","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2017.07.845_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coi.2015.12.006","article-title":"Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition","volume":"39","author":"Lau","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jid.2017.07.845_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ccell.2016.05.017","article-title":"The multifaceted role of perivascular macrophages in tumors","volume":"30","author":"Lewis Claire","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2017.07.845_bib25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/molehr\/gam055","article-title":"Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein","volume":"13","author":"Li","year":"2007","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.jid.2017.07.845_bib26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.stem.2011.10.001","article-title":"Nodal\/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy","volume":"9","author":"Lonardo","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jid.2017.07.845_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/cancers7010070","article-title":"Intertwining of Activin A and TGFbeta signaling: dual roles in cancer progression and cancer cell invasion","volume":"7","author":"Loomans","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.jid.2017.07.845_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5021\/ad.2013.25.2.135","article-title":"Insights into the transforming growth factor-beta signaling pathway in cutaneous melanoma","volume":"25","author":"Perrot","year":"2013","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jid.2017.07.845_bib29","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1158\/0008-5472.CAN-09-0781","article-title":"Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination","volume":"69","author":"Pinner","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2017.07.845_bib30","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.09.013","article-title":"Loss of Activin receptor type 1B accelerates development of intraductal papillary mucinous neoplasms in mice with activated KRAS","volume":"150","author":"Qiu","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jid.2017.07.845_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-1-13","article-title":"The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis","volume":"1","author":"Riker","year":"2008","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.jid.2017.07.845_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/1523-1747.ep12477822","article-title":"Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes","volume":"97","author":"Rodeck","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.07.845_bib33","first-page":"547","article-title":"Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells","volume":"59","author":"Rodeck","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2017.07.845_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.2009.04568.x","article-title":"Antitumor immunity and cancer stem cells","volume":"1176","author":"Schatton","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jid.2017.07.845_bib35","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1182\/blood-2011-03-342691","article-title":"The yin and yang of Activin A","volume":"117","author":"Sozzani","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jid.2017.07.845_bib36","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1038\/sj.onc.1207699","article-title":"Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition","volume":"23","author":"Stove","year":"2004","journal-title":"Oncogene"},{"issue":"Suppl","key":"10.1016\/j.jid.2017.07.845_bib37","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1097-0142(197905)43:5+<2004::AID-CNCR2820430708>3.0.CO;2-#","article-title":"Cancer cachexia","volume":"43","author":"Theologides","year":"1979","journal-title":"Cancer"},{"issue":"Pt B","key":"10.1016\/j.jid.2017.07.845_bib38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.canlet.2014.10.037","article-title":"Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer","volume":"356","author":"Togashi","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jid.2017.07.845_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1476-4598-13-126","article-title":"Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer","volume":"13","author":"Togashi","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jid.2017.07.845_bib40","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm1448","article-title":"Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness","volume":"12","author":"Topczewska","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2017.07.845_bib41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20041130","article-title":"Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells","volume":"200","author":"Turk","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2017.07.845_bib42","first-page":"1887","article-title":"Melanoma-associated expression of transforming growth factor-beta isoforms","volume":"148","author":"Van Belle","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2017.07.845_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2011.06.030","article-title":"New insights into the mechanisms of activin action and inhibition","volume":"359","author":"Walton","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jid.2017.07.845_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1755-148X.2012.00986.x","article-title":"Systematic classification of melanoma cells by phenotype-specific gene expression mapping","volume":"25","author":"Widmer","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2017.07.845_bib45","first-page":"4371","article-title":"Activin A as a novel biomarker for colorectal adenocarcinoma in humans","volume":"19","author":"Wu","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jid.2017.07.845_bib46","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.molcel.2008.11.002","article-title":"Inhibition of PAX3 by TGF-\u03b2 modulates melanocyte viability","volume":"32","author":"Yang","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.jid.2017.07.845_bib47","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.ajpath.2012.08.027","article-title":"TGF-beta signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells","volume":"181","author":"Yin","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2017.07.845_bib48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17328208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17328208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T17:59:57Z","timestamp":1555351197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17328208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0022202X17328208"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.07.845","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/144857","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.07.845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}